Therefore, we reasoned that identifying transcription factors (TF) enriched at regions with altered chromatin states would allow us to determine the mechanism that links BCR signaling to epigenetic regulation of AE activity and APOBEC3 expression in CLL B cells. The gene discussed is TF; the disease is B-cell chronic lymphocytic leukemia.